Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 4 May 2006 |
| Novozymes, group financial statement for first quarter of 2006 | 26 Apr 2006 |
| Novozymes, Novozymes A/S, annual shareholder meeting 2006 | 2 Mar 2006 |
| Novozymes, Trading by insiders in Novozymes A/S B shares | 22 Feb 2006 |
| Novozymes, Trading by insiders in Novozymes A/S B shares | 21 Feb 2006 |